Caterina Di Lauro Selected Research

tau Proteins (tau Protein)

1/2022	TNAP upregulation is a critical factor in Tauopathies and its blockade ameliorates neurotoxicity and increases life-expectancy.
1/2022	P2X7 receptor blockade reduces tau induced toxicity, therapeutic implications in tauopathies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caterina Di Lauro Research Topics

Disease

4	Alzheimer Disease (Alzheimer's Disease) 06/2023 - 01/2019
4	Neuroinflammatory Diseases 01/2023 - 01/2019
3	Tauopathies 01/2023 - 01/2022
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2019
1	Cognitive Dysfunction 06/2023
1	Autism Spectrum Disorder 12/2022
1	Intellectual Disability (Idiocy) 12/2022
1	Pick Disease of the Brain (Pick's Disease) 01/2022
1	Memory Disorders (Memory Loss) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Amyloid Plaque 01/2019

Drug/Important Bio-Agent (IBA)

4	Purinergic P2X7 ReceptorsIBA 01/2023 - 01/2019
4	Adenosine Triphosphate (ATP)IBA 01/2023 - 01/2019
2	tau Proteins (tau Protein)IBA 01/2022 - 01/2022
2	Amyloid (Amyloid Fibrils)IBA 01/2020 - 01/2019
1	Biomarkers (Surrogate Marker)IBA 06/2023
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023
1	UbiquitinIBA 01/2023
1	Histone MethyltransferasesIBA 12/2022
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Peptides (Polypeptides)IBA 01/2019

Therapy/Procedure

1	Therapeutics 01/2022